SPITALI, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 1.336
EU - Europa 496
AS - Asia 184
Totale 2.016
Nazione #
US - Stati Uniti d'America 1.335
PL - Polonia 216
CN - Cina 114
UA - Ucraina 75
DE - Germania 52
IT - Italia 47
GB - Regno Unito 40
TR - Turchia 28
SE - Svezia 24
SG - Singapore 22
FI - Finlandia 16
ID - Indonesia 7
BE - Belgio 5
NL - Olanda 5
CZ - Repubblica Ceca 4
IN - India 4
VN - Vietnam 4
IR - Iran 3
RU - Federazione Russa 3
ES - Italia 2
FR - Francia 2
BG - Bulgaria 1
CA - Canada 1
CH - Svizzera 1
HK - Hong Kong 1
MK - Macedonia 1
PT - Portogallo 1
RO - Romania 1
TW - Taiwan 1
Totale 2.016
Città #
Warsaw 216
Fairfield 185
Woodbridge 185
Chandler 120
Ashburn 112
Houston 91
Ann Arbor 86
Seattle 83
Jacksonville 80
Wilmington 64
Cambridge 54
Beijing 31
Izmir 21
Nanjing 20
Shanghai 19
Princeton 17
San Diego 15
Singapore 15
Boardman 14
Dearborn 14
Bremen 11
Ferrara 10
Milan 10
New York 9
San Mateo 8
Tianjin 7
Falls Church 6
Jakarta 6
Jiaxing 6
Nanchang 6
Auburn Hills 5
Brussels 5
Los Angeles 5
Washington 5
Brno 4
Cagliari 4
Dong Ket 4
Hebei 4
Shenyang 4
Zhengzhou 4
Changsha 3
Des Moines 3
Leiden 3
London 3
Mountain View 3
Norwalk 3
Redwood City 3
Ardabil 2
Bologna 2
Borgo Val di Taro 2
Helsinki 2
Kunming 2
Leawood 2
Munich 2
Ningbo 2
Philadelphia 2
Augusta 1
Belmont 1
Bern 1
Central 1
Changchun 1
Chicago 1
Chiswick 1
Cupertino 1
Ferrara di Monte Baldo 1
Hangzhou 1
Hollywood 1
Hounslow 1
Irkutsk 1
Jinan 1
Lisbon 1
Montreal 1
Napoli 1
Orange 1
Phoenix 1
Rueil-Malmaison 1
Sabz 1
Saint Petersburg 1
Taipei 1
Taizhou 1
Trebaseleghe 1
Valencia 1
Verona 1
Walnut 1
Wuhan 1
Totale 1.633
Nome #
ANTISENSE MEDIATED DYSTROPHIN READING FRAME RESTORATION 189
A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures 149
Exon skipping-mediated dystrophin reading frame restoration for small mutations 138
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 137
null 131
Transthyretin RNA profiling in livers from transplanted patients affected by familial amyloidotic polyneuropathy, and identification of a dual transcription start point. 130
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 125
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 115
Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5′ mutation hot spot of the dystrophin gene 111
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 111
Transcriptional behavior of DMD gene duplications in DMD/BMD males 108
Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human. 102
null 101
null 99
null 94
Antisense oligonucleotides capable of inducing exon skipping in dystrophin gene and their use in treatment of duchenne muscular dystrophy 93
Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies 27
Genomic and transcription studies as diagnostic tools for a prenatal detection of X-linked dilated cardiomyopathy due to a dystrophin gene mutation. 25
Accurate quantification of dystrophin mRNA and exon skipping levels in Duchenne Muscular Dystrophy 25
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 20
G.P.3.02 In vivo biodistribution of non-viral systems for oligoribonucleotides delivery 14
Totale 2.044
Categoria #
all - tutte 7.376
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.376


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020462 0 28 29 72 39 53 48 60 43 47 28 15
2020/2021323 27 31 22 47 15 28 13 29 15 35 46 15
2021/2022221 12 11 34 6 9 7 19 9 12 8 24 70
2022/2023246 18 33 3 42 52 30 9 19 26 2 8 4
2023/2024142 12 20 11 1 18 28 3 15 0 2 0 32
2024/202520 15 5 0 0 0 0 0 0 0 0 0 0
Totale 2.044